Healthcare research from Johnson & Johnson, page 2
A filtered view. Show the full list.
Refine
Listings
-
ArticlePregnancy (Hoboken, N.J.)
Characterization of the clinical course of early-onset severe hemolytic disease of the fetus and newborn
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleCPT: pharmacometrics & systems pharmacology
Some Common Dose-Exposure-Response Estimands and Conditions for Their Causal Identifiability
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleCPT: pharmacometrics & systems pharmacology
MBMA Bridging Models as a Tool for Exploration of Clinical Endpoints in Unstudied Indications
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleCPT: pharmacometrics & systems pharmacology
Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung Cancer
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
EditorialCPT: pharmacometrics & systems pharmacology
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticlePharmaceutical statistics
Advancing Drug Development Through Bayesian Approaches: Insights Drawn From Practical Experience in Pharmaceutical R&D
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticlePulmonary circulation
Time to Therapy Activation and Initial Combination Therapy (TITANIC) for Patients With Pulmonary Arterial Hypertension
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticlePulmonary circulation
Use of Machine-Learning Models to Identify Clinical Features Associated With A Future Clinical Worsening Event in Patients With Pulmonary Arterial Hypertension
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleStatistics in medicine
Informative Futility Rules Based on Conditional Assurance
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleAnalytical and bioanalytical chemistry
Polyclonal antibodies targeting defined epitopes on cancer biomarker MUC16
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
Clinical trial reportCancer immunology, immunotherapy : CII
A phase I study evaluating subcutaneous administration of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced solid malignancies
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportCancer immunology, immunotherapy : CII
A phase 1 study of VAC85135, a neoantigen vaccine regimen targeting calreticulin and JAK2 mutations, in combination with ipilimumab in patients with myeloproliferative neoplasms
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportCancer chemotherapy and pharmacology
A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source
Clinical careAdded
-
Clinical trial reportJournal of neurology
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportJournal of neurology
Health-related quality of life outcomes with nipocalimab versus placebo in generalized myasthenia gravis: an analysis of the Vivacity-MG3 study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticlePharmaceutical research
Investigation into Clearance of Organic Compounds from Biomanufacturing Process Streams during Ultrafiltration/Diafiltration
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleTargeted oncology
Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Clinical careAdded
-
ReviewAdvances in therapy
Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleAdvances in therapy
Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleAdvances in therapy
FREEDOMM: Fifth-Line or Later Real-World Evaluation of Efficacy and Disease Outcomes in Multiple Myeloma with Ciltacabtagene Autoleucel: Treatment-Free Interval and Overall Survival in the USA
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleAdvances in therapy
Racial and Ethnic Patterns Observed in Inflammatory Bowel Disease Prevalence, Clinical Burden, and Healthcare Resource Utilization in the United States: Findings from an Administrative Claims Database
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded
-
ArticleAdvances in therapy
Real-World PSA Response and Overall Survival Among Men with mCSPC Receiving Apalutamide Versus Darolutamide (Both Without Docetaxel) in the US
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleAdvances in therapy
BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewAdvances in therapy
Golimumab for the Treatment of Axial Spondyloarthritis: Integrating Clinical Outcomes with Real-World Patient Benefits
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded